MRVI
Maravai Lifesciences Holdings Inc
NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY
$4.74
+0.21% today
Updated 2026-06-03
Market cap
$1.85B
P/E ratio
—
P/S ratio
9.04x
EPS (TTM)
$-0.71
Dividend yield
—
52W range
$2 – $5
Volume
2.4M
Maravai Lifesciences Holdings Inc (MRVI) Insider transactions
Net insider activity
Net selling (5,435,648 shares)
Buy transactions
61
Sell transactions
39
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-16 | ORESHACK, KURT | General Counsel | Sale | 39,976 | $3.08 | $123126.08 |
| 2026-03-16 | DOLAN, CHRISTINE | See Remarks | Sale | 28,661 | $3.08 | $88275.88 |
| 2026-01-15 | ORESHACK, KURT | General Counsel | Sale | 31,902 | $3.69 | $117718.38 |
| 2026-01-15 | DOLAN, CHRISTINE | See Remarks | Sale | 28,934 | $3.69 | $106766.46 |
| 2025-12-08 | LUCIER, GREGORY T | Director | Buy | 48,528 | $3.67 | $178097.76 |
| 2025-12-05 | LUCIER, GREGORY T | Director | Buy | 51,472 | $3.70 | $190446.40 |
| 2025-11-14 | DOLAN, CHRISTINE | See Remarks | Buy | 4,300 | $1.79 | $7697.00 |
| 2025-11-13 | BRUST, BERND | Director, Chief Executive Officer | Buy | 216,212 | $3.25 | $702689.00 |
| 2025-11-12 | BRUST, BERND | Director, Chief Executive Officer | Buy | 93,358 | $3.21 | $299679.18 |
| 2025-11-11 | BRUST, BERND | Director, Chief Executive Officer | Buy | 157,201 | $3.24 | $509331.24 |
| 2025-07-15 | LEDDY, PETER MICHAEL | See Remarks | Sale | 5,154 | $2.59 | $13348.86 |
| 2025-07-10 | LUCIER, GREGORY T | Director | Buy | 89,139 | — | — |
| 2025-06-30 | ASARPOTA, RAJESH | Chief Financial Officer | Buy | 750,000 | — | — |
| 2025-06-30 | ASARPOTA, RAJESH | Chief Financial Officer | Buy | 333,333 | — | — |
| 2025-06-30 | ASARPOTA, RAJESH | Chief Financial Officer | Buy | 500,000 | — | — |
| 2025-06-16 | PRAHALAD, MURALI | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | MIHAS, CONSTANTINE S | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | MARKER, LUKE JOSEPH | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | LUCIER, GREGORY T | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | HOPFIELD, JESSICA | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | GRAY, SUSANNAH | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | ECKERT, R ANDREW | Director | Buy | 231,481 | $2.16 | $499998.96 |
| 2025-06-16 | DEFORD, JOHN A | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | DAVERMAN, BENJAMIN JAMES | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-16 | CUNNINGHAM, SEAN LAURENCE | Director | Buy | 89,139 | $2.16 | $192540.24 |
| 2025-06-08 | BRUST, BERND | Director, Chief Executive Officer | Buy | 2,250,000 | — | — |
| 2025-06-08 | BRUST, BERND | Director, Chief Executive Officer | Buy | 1,000,000 | — | — |
| 2025-06-08 | BRUST, BERND | Director, Chief Executive Officer | Buy | 2,000,000 | — | — |
| 2025-05-15 | HERDE, KEVIN | Chief Financial Officer | Buy | 876 | $1.67 | $1462.92 |
| 2025-05-15 | DOLAN, CHRISTINE | See Remarks | Buy | 2,381 | $1.67 | $3976.27 |
| 2025-03-17 | ORESHACK, KURT | General Counsel | Buy | 295,858 | — | — |
| 2025-03-17 | ORESHACK, KURT | General Counsel | Sale | 4,579 | $2.64 | $12088.56 |
| 2025-03-17 | MARTIN, WILLIAM E. III | Chief Executive Officer | Buy | 986,194 | — | — |
| 2025-03-17 | LEDDY, PETER MICHAEL | See Remarks | Buy | 394,478 | — | — |
| 2025-03-17 | LEDDY, PETER MICHAEL | See Remarks | Sale | 5,886 | $2.64 | $15539.04 |
| 2025-03-17 | HERDE, KEVIN | Chief Financial Officer | Buy | 394,478 | — | — |
| 2025-03-17 | HERDE, KEVIN | Chief Financial Officer | Sale | 8,648 | $2.64 | $22830.72 |
| 2025-03-17 | DOLAN, CHRISTINE | See Remarks | Buy | 246,549 | — | — |
| 2025-03-17 | DOLAN, CHRISTINE | See Remarks | Sale | 5,336 | $2.64 | $14087.04 |
| 2025-03-17 | BUZZEO, REBECCA | See Remarks | Buy | 295,858 | — | — |
| 2025-03-17 | BUZZEO, REBECCA | See Remarks | Sale | 4,314 | $2.64 | $11388.96 |
| 2025-02-18 | ORESHACK, KURT | General Counsel | Sale | 2,028 | $4.10 | $8314.80 |
| 2025-02-18 | HERDE, KEVIN | Chief Financial Officer | Sale | 2,326 | $4.10 | $9536.60 |
| 2025-02-18 | DOLAN, CHRISTINE | See Remarks | Sale | 1,621 | $4.10 | $6646.10 |
| 2025-01-31 | ORESHACK, KURT | General Counsel | Sale | 25,000 | $5.03 | $125750.00 |
| 2025-01-15 | ORESHACK, KURT | General Counsel | Sale | 31,438 | $4.56 | $143357.28 |
| 2025-01-15 | MARTIN, WILLIAM E. III | Chief Executive Officer | Sale | 160,981 | $4.56 | $734073.36 |
| 2025-01-15 | LEDDY, PETER MICHAEL | See Remarks | Sale | 32,042 | $4.56 | $146111.52 |
| 2025-01-15 | HERDE, KEVIN | Chief Financial Officer | Sale | 46,344 | $4.56 | $211328.64 |
| 2025-01-15 | DOLAN, CHRISTINE | See Remarks | Sale | 28,704 | $4.56 | $130890.24 |
| 2025-01-15 | BUZZEO, REBECCA | See Remarks | Sale | 45,456 | $4.56 | $207279.36 |
| 2025-01-15 | BURCH, ANDREW | See Remarks | Sale | 54,412 | $4.56 | $248118.72 |
| 2024-12-16 | ECKERT, R ANDREW | Director | Buy | 134,409 | — | — |
| 2024-12-09 | LUCIER, GREGORY T | Director | Sale | 20,645 | — | — |
| 2024-11-15 | BUZZEO, REBECCA | See Remarks | Sale | 4,363 | $4.42 | $19284.46 |
| 2024-11-12 | DEFORD, JOHN A | Director | Buy | 17,500 | $5.75 | $100625.00 |
| 2024-11-11 | HULL, CARL | Director, See Remarks | Buy | 175,000 | $5.64 | $987000.00 |
| 2024-10-31 | ORESHACK, KURT | General Counsel | Buy | 366 | $5.70 | $2086.20 |
| 2024-10-31 | HERDE, KEVIN | Chief Financial Officer | Buy | 1,906 | $5.70 | $10864.20 |
| 2024-10-31 | DOLAN, CHRISTINE | See Remarks | Buy | 1,848 | $5.70 | $10533.60 |
| 2024-10-31 | BURCH, ANDREW | See Remarks | Buy | 1,841 | $5.70 | $10493.70 |
| 2024-10-15 | MARTIN, WILLIAM E. III | Chief Executive Officer | Sale | 50,843 | $8.29 | $421488.47 |
| 2024-07-15 | LEDDY, PETER MICHAEL | See Remarks | Sale | 5,154 | $8.76 | $45149.04 |
| 2024-05-28 | GTCR, INVESTMENT XI LLC | Director, 10% Owner | Sale | 8,409,946 | — | — |
| 2024-05-28 | GTCR, INVESTMENT XI LLC | Director, 10% Owner | Sale | 8,409,946 | — | — |
| 2024-05-28 | GTCR, INVESTMENT XI LLC | Director, 10% Owner | Sale | 9,940,974 | $9.82 | $97.57M |
| 2024-05-28 | GTCR, INVESTMENT XI LLC | Director, 10% Owner | Buy | 8,409,946 | — | — |
| 2024-05-23 | PRAHALAD, MURALI | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | MIHAS, CONSTANTINE S | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | MARKER, LUKE JOSEPH | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | LUCIER, GREGORY T | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | HOPFIELD, JESSICA | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | GRAY, SUSANNAH | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | DEFORD, JOHN A | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | DAVERMAN, BENJAMIN JAMES | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | CUNNINGHAM, SEAN LAURENCE | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-05-23 | ASHKENAZI, ANAT | Director | Buy | 20,645 | $10.78 | $222553.10 |
| 2024-04-30 | ORESHACK, KURT | General Counsel | Buy | 341 | $5.70 | $1943.70 |
| 2024-04-30 | LEDDY, PETER MICHAEL | See Remarks | Buy | 4,576 | $5.70 | $26083.20 |
| 2024-04-30 | HERDE, KEVIN | Chief Financial Officer | Buy | 1,780 | $5.70 | $10146.00 |
| 2024-04-30 | DOLAN, CHRISTINE | See Remarks | Buy | 483 | $5.70 | $2753.10 |
| 2024-04-30 | BURCH, ANDREW | See Remarks | Buy | 1,719 | $5.70 | $9798.30 |
| 2024-04-15 | BURCH, ANDREW | See Remarks | Sale | 16,758 | $8.11 | $135907.38 |
| 2024-03-15 | ORESHACK, KURT | General Counsel | Sale | 4,551 | $7.70 | $35042.70 |
| 2024-03-15 | LEDDY, PETER MICHAEL | See Remarks | Sale | 6,714 | $7.70 | $51697.80 |
| 2024-03-15 | HULL, CARL | Director, See Remarks | Sale | 17,560 | $7.70 | $135212.00 |
| 2024-03-15 | HERDE, KEVIN | Chief Financial Officer | Sale | 8,624 | $7.70 | $66404.80 |
| 2024-03-15 | DOLAN, CHRISTINE | See Remarks | Sale | 5,383 | $7.70 | $41449.10 |
| 2024-03-15 | BUZZEO, REBECCA | See Remarks | Sale | 4,366 | $7.70 | $33618.20 |
| 2024-02-15 | ORESHACK, KURT | General Counsel | Sale | 2,322 | $5.48 | $12724.56 |
| 2024-02-15 | HULL, CARL | Director, See Remarks | Sale | 10,729 | $5.48 | $58794.92 |
| 2024-02-15 | HERDE, KEVIN | Chief Financial Officer | Sale | 2,664 | $5.48 | $14598.72 |
| 2024-02-15 | DOLAN, CHRISTINE | See Remarks | Sale | 1,941 | $5.48 | $10636.68 |
| 2024-01-16 | ORESHACK, KURT | General Counsel | Buy | 166,852 | — | — |
| 2024-01-16 | MARTIN, WILLIAM E. III | Chief Executive Officer | Buy | 758,415 | — | — |
| 2024-01-16 | LEDDY, PETER MICHAEL | See Remarks | Buy | 250,277 | — | — |
| 2024-01-16 | HULL, CARL | Director, See Remarks | Buy | 75,842 | — | — |
| 2024-01-16 | HERDE, KEVIN | Chief Financial Officer | Buy | 250,277 | — | — |
| 2024-01-16 | DOLAN, CHRISTINE | See Remarks | Buy | 189,604 | — | — |
| 2024-01-16 | BUZZEO, REBECCA | See Remarks | Buy | 288,198 | — | — |
Frequently asked questions
Are MRVI insiders buying or selling?
Over the transactions on record, MRVI insiders have been net buyers, with about $101.15M in stock sold across 39 sales, against 39 open-market purchases.
Does insider selling at MRVI mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which MRVI insiders are selling the most?
Recent selling is concentrated in a few names. GTCR, INVESTMENT XI LLC accounts for the largest share on record, with about $97.57M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.